Trial intelligence / Profile preview

Antistax in Chronic Venous Insufficiency

NCT02191254Phase 3Completed

Sponsor
Boehringer Ingelheim
Start
Apr 2004
Primary completion
Oct 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of Red vine leaf extract in chronic venous insufficiency (CVI), sponsored by Boehringer Ingelheim. Started Apr 2004; status: completed.

02

Drugs

Red vine leaf extract
03

Conditions

chronic venous insufficiency (CVI)

Beyond the preview

Go deeper on NCT02191254.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02191254.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call